452 related articles for article (PubMed ID: 19491303)
1. Phase 2 enzyme inducer sulphoraphane blocks matrix metalloproteinase production in articular chondrocytes.
Kim HA; Yeo Y; Kim WU; Kim S
Rheumatology (Oxford); 2009 Aug; 48(8):932-8. PubMed ID: 19491303
[TBL] [Abstract][Full Text] [Related]
2. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes.
Kim HA; Cho ML; Choi HY; Yoon CS; Jhun JY; Oh HJ; Kim HY
Arthritis Rheum; 2006 Jul; 54(7):2152-63. PubMed ID: 16802353
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid blocks pro-inflammatory cytokine-induced matrix metalloproteinase production by down-regulating JNK-AP-1 signaling in human chondrocytes.
Ho LJ; Lin LC; Hung LF; Wang SJ; Lee CH; Chang DM; Lai JH; Tai TY
Biochem Pharmacol; 2005 Jul; 70(2):200-8. PubMed ID: 15946654
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
Tetlow LC; Adlam DJ; Woolley DE
Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
[TBL] [Abstract][Full Text] [Related]
5. Phase 2 enzyme inducer sulphoraphane blocks prostaglandin and nitric oxide synthesis in human articular chondrocytes and inhibits cartilage matrix degradation.
Kim HA; Yeo Y; Jung HA; Jung YO; Park SJ; Kim SJ
Rheumatology (Oxford); 2012 Jun; 51(6):1006-16. PubMed ID: 22332123
[TBL] [Abstract][Full Text] [Related]
6. Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-κB nuclear translocation.
Zhong HM; Ding QH; Chen WP; Luo RB
Int Immunopharmacol; 2013 Oct; 17(2):329-35. PubMed ID: 23856614
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3.
Mengshol JA; Vincenti MP; Coon CI; Barchowsky A; Brinckerhoff CE
Arthritis Rheum; 2000 Apr; 43(4):801-11. PubMed ID: 10765924
[TBL] [Abstract][Full Text] [Related]
8. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis.
Shlopov BV; Gumanovskaya ML; Hasty KA
Arthritis Rheum; 2000 Jan; 43(1):195-205. PubMed ID: 10643716
[TBL] [Abstract][Full Text] [Related]
9. Effects of curcumin (diferuloylmethane) on nuclear factor kappaB signaling in interleukin-1beta-stimulated chondrocytes.
Schulze-Tanzil G; Mobasheri A; Sendzik J; John T; Shakibaei M
Ann N Y Acad Sci; 2004 Dec; 1030():578-86. PubMed ID: 15659840
[TBL] [Abstract][Full Text] [Related]
10. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.
Shakibaei M; John T; Schulze-Tanzil G; Lehmann I; Mobasheri A
Biochem Pharmacol; 2007 May; 73(9):1434-45. PubMed ID: 17291458
[TBL] [Abstract][Full Text] [Related]
11. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes.
Pufe T; Harde V; Petersen W; Goldring MB; Tillmann B; Mentlein R
J Pathol; 2004 Mar; 202(3):367-74. PubMed ID: 14991903
[TBL] [Abstract][Full Text] [Related]
14. A Wnt/β-catenin negative feedback loop inhibits interleukin-1-induced matrix metalloproteinase expression in human articular chondrocytes.
Ma B; van Blitterswijk CA; Karperien M
Arthritis Rheum; 2012 Aug; 64(8):2589-600. PubMed ID: 22328140
[TBL] [Abstract][Full Text] [Related]
15. Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1.
Ahmed S; Rahman A; Hasnain A; Goldberg VM; Haqqi TM
J Pharmacol Exp Ther; 2003 Jun; 305(3):981-8. PubMed ID: 12626640
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts.
Okuno T; Andoh A; Bamba S; Araki Y; Fujiyama Y; Fujiyama M; Bamba T
Scand J Gastroenterol; 2002 Mar; 37(3):317-24. PubMed ID: 11916194
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
Andriamanalijaona R; Kypriotou M; Baugé C; Renard E; Legendre F; Raoudi M; Boumediene K; Gatto H; Monginoux P; Pujol JP
J Rheumatol; 2005 Oct; 32(10):1958-67. PubMed ID: 16206353
[TBL] [Abstract][Full Text] [Related]
18. Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes.
Ge X; Ma X; Meng J; Zhang C; Ma K; Zhou C
Arthritis Rheum; 2009 Sep; 60(9):2714-22. PubMed ID: 19714632
[TBL] [Abstract][Full Text] [Related]
19. Hsp90{beta} and p130(cas): novel regulatory factors of MMP-13 expression in human osteoarthritic chondrocytes.
Fan Z; Tardif G; Hum D; Duval N; Pelletier JP; Martel-Pelletier J
Ann Rheum Dis; 2009 Jun; 68(6):976-82. PubMed ID: 18593760
[TBL] [Abstract][Full Text] [Related]
20. Differential Toll-like receptor-dependent collagenase expression in chondrocytes.
Zhang Q; Hui W; Litherland GJ; Barter MJ; Davidson R; Darrah C; Donell ST; Clark IM; Cawston TE; Robinson JH; Rowan AD; Young DA
Ann Rheum Dis; 2008 Nov; 67(11):1633-41. PubMed ID: 18258708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
